InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Marshall Urist, a EVP, Research & Investments, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 16 open-market SEC Form 4 transactions: 0 purchases worth $0 and 16 sales worth $12.5M, reported from May 16, 22 to Jul 1, 26. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 1, 26 | RPRXRoyalty Pharma plc | SELL | 9.1K | $55.88 | $508K |
| Jan 30, 26 | RPRXRoyalty Pharma plc | SELL | 20.0K | $41.09 | $822K |
| Jan 23, 26 | RPRXRoyalty Pharma plc | SELL | 20.0K | $40.26 | $805K |
| Jan 16, 26 | RPRXRoyalty Pharma plc | SELL | 20.0K | $39.52 | $790K |
| Jan 9, 26 | RPRXRoyalty Pharma plc | SELL | 20.0K | $40.78 | $816K |
| Jan 2, 26 | RPRXRoyalty Pharma plc | SELL | 20.0K | $38.48 | $770K |
| Dec 26, 25 | RPRXRoyalty Pharma plc | SELL | 20.0K | $39.32 | $786K |
| Dec 19, 25 | RPRXRoyalty Pharma plc | SELL | 20.0K | $38.38 | $768K |
| Dec 16, 25 | RPRXRoyalty Pharma plc | SELL | 20.0K | $38.32 | $766K |
| Dec 5, 25 | RPRXRoyalty Pharma plc | SELL | 23.3K | $39.15 | $914K |
| Dec 1, 25 | RPRXRoyalty Pharma plc | SELL | 23.3K | $39.93 | $932K |
| Feb 22, 23 | RPRXRoyalty Pharma plc | SELL | 23.3K | $37.30 | $870K |
| Jul 26, 22 | RPRXRoyalty Pharma plc | SELL | 19.7K | $43.20 | $853K |
| Jul 25, 22 | RPRXRoyalty Pharma plc | SELL | 3.6K | $43.05 | $155K |
| Jun 24, 22 | RPRXRoyalty Pharma plc | SELL | 23.3K | $43.19 | $1.0M |
| May 16, 22 | RPRXRoyalty Pharma plc | SELL | 23.3K | $39.85 | $930K |